Company
Our Team
The scientists of PRO Consulting have more than 100 collective years experience capturing and reporting patient reported outcomes (PRO) data to support drug and medical device development programs worldwide. Our experience includes consulting on more than 300 U.S. and international clinical trials, including participation in Scientific Advisory Boards for a variety of biotechnology and pharmaceutical companies.Our consultants also have extensive experience with the FDA, EMEA and other regulatory bodies. The FDA has repeatedly invited our consultants to present to CDER reviewers regarding PRO data and their role in the drug and medical device development process.
PRO Consulting has the most complete and diverse team of scientists experienced in the area of patient reported outcome (PRO) methods and measurements.
Senior Scientists
Jean Paty, Ph.D. – Chief Scientist and Regulatory Advisor
Saul Shiffman, Ph.D. – Senior Scientific Consultant
Arthur Stone, Ph.D. – Senior Scientific Consultant
Brian Tiplady, Ph.D. – Senior Scientific Consultant
Scientists & Scientific Consultants
Alan Shields, Ph.D. – Scientist
Chad Gwaltney, Ph.D. – Scientist
Celeste Elash, M.S. – Scientific Consultant
Management Team
Bob Young – President, PRO Consulting
Peter M. Black, M.S. – Vice President of Operations, PRO Consulting
David Secker, M.A. – Commercial Director, PRO Consulting
Jean Paty, Ph.D. – Chief Scientist and Regulatory Advisor
Saul Shiffman, Ph.D. – Senior Scientific Consultant
Arthur Stone, Ph.D. – Senior Scientific Consultant
Brian Tiplady, Ph.D. – Senior Scientific Consultant
Scientists & Scientific Consultants
Alan Shields, Ph.D. – Scientist
Chad Gwaltney, Ph.D. – Scientist
Celeste Elash, M.S. – Scientific Consultant
Management Team
Bob Young – President, PRO Consulting
Peter M. Black, M.S. – Vice President of Operations, PRO Consulting
David Secker, M.A. – Commercial Director, PRO Consulting